Less than a week after federal authorities unsealed an indictment accusing the Hi-Tech Pharmaceuticals CEO of wire fraud, money laundering and other charges, a federal judge has ordered him, his company and an associate to pay more than $40 million to resolve an unrelated civil matter.

Read the full article:
ajc.com